{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:05:58Z","timestamp":1784167558724,"version":"3.55.0"},"reference-count":30,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Lymph node (LN) involvement (LNI) is not infrequently observed in ovarian serous borderline tumors (SBTs) but is not considered equivalent to malignant tumor metastasis, as it reportedly does not impact recurrence or survival in patients with SBT. However, the reasons underlying the insignificant clinical impact of LNI remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To determine whether histologic reaction patterns (HRPs) are associated with SBT prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We compared HRPs around tumor cell clusters in LNs of patients with SBT and low-grade serous carcinoma. HRPs were classified into 4 categories (HRP 1\u2013HRP 4) based on tumor cell location in LNs, the presence of their adhesion to surrounding lymphoid tissue, or pericellular desmoplastic reactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Although LNI itself was linked to reduced recurrence-free survival (RFS), no recurrence was observed in patients with HRP 1 or 2, characterized by freely floating tumor cells in the lumens of afferent\/efferent lymphatics or intranodal sinus with surrounding free spaces. Conversely, HRP 3 or higher, characterized by firm tumor cell adhesion to lymphoid tissue (HRP 3) or peritumoral desmoplastic reaction (HRP 4), independently impacted RFS, albeit not overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>The prognosis of SBT with LNI is not uniformly favorable, and HRPs around the LNI significantly influence patient outcomes. Patients with firm tumor cell adhesion to surrounding tissue, with or without peritumoral desmoplastic reaction (HRP \u22653), independently experience decreased RFS, although this does not correlate with reduced overall survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2024-0191-oa","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T22:18:26Z","timestamp":1733696306000},"page":"643-651","source":"Crossref","is-referenced-by-count":0,"title":["Histologic Reaction Patterns of Lymph Node Involvement in Ovarian Serous Borderline Tumors: Their Implications for Prognosis"],"prefix":"10.5858","volume":"149","author":[{"given":"Jisup","family":"Kim","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea (J. Kim)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Rae","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department Department of Pathology, Seegene Medical Foundation, Seoul, Republic of Korea (K.-R. Kim)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"6","key":"i1543-2165-149-7-643-b01","series-title":"Am J Surg Pathol","first-page":"707","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up","volume":"29","author":"Longacre","year":"2005","unstructured":"Longacre\n              TA\n            ,\nMcKenneyJK,\nTazelaarHD,\nKempsonRL,\nHendricksonMR.\n          Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol. 2005;29(6):707\u2013723."},{"issue":"1","key":"i1543-2165-149-7-643-b02","series-title":"Int J Gynecol Cancer","first-page":"103","article-title":"Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors)","volume":"19","author":"Fadare","year":"2009","unstructured":"Fadare\n              O.\n            \n          \n          Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). Int J Gynecol Cancer. 2009;19(1):103\u2013108."},{"issue":"8","key":"i1543-2165-149-7-643-b03","series-title":"Hum Pathol","first-page":"934","article-title":"Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives","volume":"35","author":"Bell","year":"2004","unstructured":"Bell\n              DA\n            ,\nLongacreTA,\nPratJ, et al.\n          Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol. 2004;35(8):934\u2013948."},{"key":"i1543-2165-149-7-643-b04","series-title":"Cancer Manag Res","first-page":"1529","article-title":"Predicting lymph node involvement in borderline ovarian tumors with a quantitative model and nomogram: a retrospective cohort study","volume":"13","author":"Zhang","year":"2021","unstructured":"Zhang\n              M\n            ,\nZhouF,\nHeY,\nTaoX,\nHuaK,\nDingJ.\n          Predicting lymph node involvement in borderline ovarian tumors with a quantitative model and nomogram: a retrospective cohort study. Cancer Manag Res. 2021;13:1529\u20131539."},{"issue":"2","key":"i1543-2165-149-7-643-b05","series-title":"Gynecol Oncol","first-page":"124","article-title":"Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential","volume":"42","author":"Leake","year":"1991","unstructured":"Leake\n              JF\n            ,\nRaderJS,\nWoodruffJD,\nRosensheinNB.\n          Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol. 1991;42(2):124\u2013130."},{"issue":"5","key":"i1543-2165-149-7-643-b06","series-title":"Hum Pathol","first-page":"539","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","unstructured":"Seidman\n              JD\n            ,\nKurmanRJ.\n          Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31(5):539\u2013557."},{"issue":"5","key":"i1543-2165-149-7-643-b07","series-title":"Am J Surg Pathol","first-page":"614","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification","volume":"30","author":"McKenney","year":"2006","unstructured":"McKenney\n              JK\n            ,\nBalzerBL,\nLongacreTA.\n          Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am J Surg Pathol. 2006;30(5):614\u2013624."},{"issue":"3","key":"i1543-2165-149-7-643-b08","series-title":"J Am Coll Surg","first-page":"332","article-title":"Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies","volume":"195","author":"Camatte","year":"2002","unstructured":"Camatte\n              S\n            ,\nMoriceP,\nAtallahD, et al.\n          Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg. 2002;195(3):332\u2013338."},{"issue":"4","key":"i1543-2165-149-7-643-b09","series-title":"Ann Oncol","first-page":"592","article-title":"Prognostic factors for patients with advanced stage serous borderline tumours of the ovary","volume":"14","author":"Morice","year":"2003","unstructured":"Morice\n              P\n            ,\nCamatteS,\nReyA, et al.\n          Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol. 2003;14(4):592\u2013598."},{"issue":"1","key":"i1543-2165-149-7-643-b10","series-title":"Am J Surg Pathol","first-page":"1","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases","volume":"34","author":"Djordjevic","year":"2010","unstructured":"Djordjevic\n              B\n            ,\nMalpicaA.\n          Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases. Am J Surg Pathol. 2010;34(1):1\u20139."},{"issue":"2","key":"i1543-2165-149-7-643-b11","series-title":"Int J Gynecol Cancer","first-page":"279","article-title":"Clinical predictors of recurrence and prognostic value of lymph node involvement in the serous borderline ovarian tumor","volume":"28","author":"Qian","year":"2018","unstructured":"Qian\n              XQ\n            ,\nHuaXP,\nWuJH,\nShenYM,\nChengXD,\nWanXY.\n          Clinical predictors of recurrence and prognostic value of lymph node involvement in the serous borderline ovarian tumor. Int J Gynecol Cancer. 2018;28(2):279\u2013284."},{"issue":"5","key":"i1543-2165-149-7-643-b12","series-title":"Int J Gynecol Cancer","first-page":"310","article-title":"Surgical staging for epithelial ovarian tumors of low malignant potential","volume":"4","author":"Di Re","year":"1994","unstructured":"Di Re\n              F\n            ,\nPaladiniD,\nFontanelliR,\nFeudaleEA,\nRaspagliesiF.\n          Surgical staging for epithelial ovarian tumors of low malignant potential. Int J Gynecol Cancer. 1994;4(5):310\u2013314."},{"issue":"5","key":"i1543-2165-149-7-643-b13","series-title":"Am J Obstet Gynecol","first-page":"438.e1","article-title":"Prognostic value of lymph node involvement in ovarian serous borderline tumors","volume":"204","author":"Lesieur","year":"2011","unstructured":"Lesieur\n              B\n            ,\nKaneA,\nDuvillardP, et al.\n          Prognostic value of lymph node involvement in ovarian serous borderline tumors. Am J Obstet Gynecol. 2011;204(5):438.e1\u2013e7."},{"issue":"2","key":"i1543-2165-149-7-643-b14","series-title":"Obstet Gynecol","first-page":"261","article-title":"Surgical staging of ovarian low malignant potential tumors","volume":"104","author":"Rao","year":"2004","unstructured":"Rao\n              GG\n            ,\nSkinnerE,\nGehrigPA,\nDuskaLR,\nColemanRL,\nSchorgeJO.\n          Surgical staging of ovarian low malignant potential tumors. Obstet Gynecol. 2004;104(2):261\u2013266."},{"issue":"1","key":"i1543-2165-149-7-643-b15","series-title":"Int J Gynecol Cancer","first-page":"66","article-title":"The factors predicting recurrence in patients with serous borderline ovarian tumor","volume":"26","author":"Ureyen","year":"2016","unstructured":"Ureyen\n              I\n            ,\nKaralokA,\nTasciT, et al.\n          The factors predicting recurrence in patients with serous borderline ovarian tumor. Int J Gynecol Cancer. 2016;26(1):66\u201372."},{"issue":"4","key":"i1543-2165-149-7-643-b16","series-title":"Int J Gynecol Pathol","first-page":"387","article-title":"Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions","volume":"26","author":"Emerson","year":"2007","unstructured":"Emerson\n              RE\n            ,\nWangM,\nLiuF,\nLawrenceWD,\nAbdul-KarimFW,\nChengL.\n          Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions. Int J Gynecol Pathol. 2007;26(4):387\u2013394."},{"issue":"12","key":"i1543-2165-149-7-643-b17","series-title":"Cold Spring Harb Perspect Med","first-page":"a041178","article-title":"Buttons and zippers: endothelial junctions in lymphatic vessels","volume":"12","author":"Baluk","year":"2022","unstructured":"Baluk\n              P\n            ,\nMcDonaldDM.\n          Buttons and zippers: endothelial junctions in lymphatic vessels. Cold Spring Harb Perspect Med. 2022;12(12):a041178."},{"issue":"9","key":"i1543-2165-149-7-643-b18","series-title":"Cancer Gene Ther","first-page":"984","article-title":"Cancer-associated fibroblasts: overview, progress, challenges, and directions","volume":"28","author":"Ping","year":"2021","unstructured":"Ping\n              Q\n            ,\nYanR,\nChengX, et al.\n          Cancer-associated fibroblasts: overview, progress, challenges, and directions. Cancer Gene Ther. 2021;28(9):984\u2013999."},{"issue":"1","key":"i1543-2165-149-7-643-b19","series-title":"Front Biosci (Landmark Ed)","first-page":"166","article-title":"Cancer associated fibroblasts (CAFs) in tumor microenvironment","volume":"15","author":"Xing","year":"2010","unstructured":"Xing\n              F\n            ,\nSaidouJ,\nWatabeK.\n          Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed). 2010;15(1):166\u2013179."},{"issue":"6","key":"i1543-2165-149-7-643-b20","series-title":"Cancers (Basel)","first-page":"1399","article-title":"The role of cancer-associated fibroblasts in tumor progression","volume":"13","author":"Joshi","year":"2021","unstructured":"Joshi\n              RS\n            ,\nKanugulaSS,\nSudhirS,\nPereiraMP,\nJainS,\nAghiMK.\n          The role of cancer-associated fibroblasts in tumor progression. Cancers (Basel). 2021;13(6):1399."},{"issue":"3","key":"i1543-2165-149-7-643-b21","series-title":"Nat Rev Cancer","first-page":"174","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","unstructured":"Sahai\n              E\n            ,\nAstsaturovI,\nCukiermanE, et al.\n          A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u2013186."},{"issue":"7","key":"i1543-2165-149-7-643-b22","series-title":"Tumour Biol","first-page":"1010428317712592","article-title":"Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1\/FGFR4 signaling","volume":"39","author":"Sun","year":"2017","unstructured":"Sun\n              Y\n            ,\nFanX,\nZhangQ,\nShiX,\nXuG,\nZouC.\n          Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1\/FGFR4 signaling. Tumour Biol. 2017;39(7):1010428317712592."},{"issue":"1","key":"i1543-2165-149-7-643-b23","series-title":"Int J Gynaecol Obstet","first-page":"1","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","unstructured":"Prat\n              J.\n            \n          \n          Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1\u20135."},{"key":"i1543-2165-149-7-643-b24","series-title":"Female Genital Tumours","first-page":"31","article-title":"Tumours of the ovary","volume":"4","author":"Cheung","year":"2019","unstructured":"Cheung\n              AN\n            ,\nEllensonLH,\nGilksCB, et al.\n          Tumours of the ovary. In: WHO Classification of Tumours Editorial Board, ed. Female Genital Tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2019:31\u2013167. WHO Classification of Tumours; vol 4."},{"issue":"6","key":"i1543-2165-149-7-643-b25","series-title":"Am J Surg Pathol","first-page":"743","article-title":"Evaluation of microinvasion and lymph node involvement in ovarian serous borderline\/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases","volume":"38","author":"Maniar","year":"2014","unstructured":"Maniar\n              KP\n            ,\nWangY,\nVisvanathanK,\nShih IeM,\nKurmanRJ.\n          Evaluation of microinvasion and lymph node involvement in ovarian serous borderline\/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases. Am J Surg Pathol. 2014;38(6):743\u2013755."},{"key":"i1543-2165-149-7-643-b26","series-title":"Front Immunol","first-page":"347","article-title":"Lymph node subcapsular sinus macrophages as the frontline of lymphatic immune defense","volume":"10","author":"Louie","year":"2019","unstructured":"Louie\n              DAP\n            ,\nLiaoS.\n          Lymph node subcapsular sinus macrophages as the frontline of lymphatic immune defense. Front Immunol. 2019;10:347."},{"issue":"3","key":"i1543-2165-149-7-643-b27","series-title":"Pancreas","first-page":"367","article-title":"Desmoplasia in lymph node metastasis of pancreatic adenocarcinoma reveals activation of cancer-associated fibroblasts pattern and T-helper 2 immune cell infiltration","volume":"48","author":"Nizri","year":"2019","unstructured":"Nizri\n              E\n            ,\nBar-DavidS,\nAizicA, et al.\n          Desmoplasia in lymph node metastasis of pancreatic adenocarcinoma reveals activation of cancer-associated fibroblasts pattern and T-helper 2 immune cell infiltration. Pancreas. 2019;48(3):367\u2013373."},{"issue":"12","key":"i1543-2165-149-7-643-b28","series-title":"Oncoimmunology","first-page":"e26788","article-title":"The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration","volume":"2","author":"Watt","year":"2013","unstructured":"Watt\n              J\n            ,\nKocherHM.\n          The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration. Oncoimmunology. 2013;2(12):e26788."},{"issue":"10","key":"i1543-2165-149-7-643-b29","series-title":"J Exp Med","first-page":"2349","article-title":"Functionally specialized junctions between endothelial cells of lymphatic vessels","volume":"204","author":"Baluk","year":"2007","unstructured":"Baluk\n              P\n            ,\nFuxeJ,\nHashizumeH, et al.\n          Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204(10):2349\u20132362."},{"key":"i1543-2165-149-7-643-b30","series-title":"WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon, France","first-page":"18","article-title":"Serous borderline tumour\/atypical proliferative serous tumour","volume":"6","author":"Seidman","year":"2014","unstructured":"Seidman\n              JD\n            ,\nBellDA,\nCrumCP, et al.\n          Serous borderline tumour\/atypical proliferative serous tumour. In: KurmanRJ,\nCarcangiuML,\nYoungRH,\nHerringtonCS, eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon, France: International Agency for Research on Cancer; 2014:18\u201320. WHO Classification of Tumours; vol 6."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/7\/article-p643.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/7\/643\/3527702\/i1543-2165-149-7-643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/149\/7\/article-p643.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/149\/7\/article-p643.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:56:07Z","timestamp":1784166967000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/7\/article-p643.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2024-0191-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}